Inceptionr LLC Amgen Inc Transaction History

Inceptionr LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $56,509 - $63,749	-221 Reduced 20.37%	864 $249 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $866,728 - $1.08 Million	-3,964 Reduced 78.51%	1,085 $292 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $1.08 Million - $1.28 Million	5,049 New	5,049 $1.12 Billion

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

Stay updated on Inceptionr LLC with notifications on news.